- Report
- June 2024
- 377 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- October 2024
- 186 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 127 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- October 2024
- 264 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- September 2024
- 94 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- September 2024
- 94 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- September 2024
- 90 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- February 2023
- 180 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2024
- 180 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- February 2024
- 140 Pages
Global
From €4522EUR$4,969USD£3,877GBP
- Report
- December 2022
- 151 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- July 2024
- 233 Pages
Global
From €2416EUR$2,655USD£2,071GBP
The Custom Antibody market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and antibodies. Custom Antibodies are antibodies that are designed and produced to specifically target a particular antigen. They are used in a variety of applications, such as diagnostics, drug discovery, and therapeutic treatments. Custom Antibodies are produced through a variety of methods, including hybridoma technology, phage display, and recombinant DNA technology.
Custom Antibodies are used in a variety of research and clinical applications, including immunoassays, immunohistochemistry, flow cytometry, and ELISA. They are also used in drug discovery and development, as well as in the development of therapeutic treatments.
Some companies in the Custom Antibody market include Abcam, Bio-Rad, Merck Millipore, Thermo Fisher Scientific, and GenScript. Show Less Read more
